Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Armando Santoro, MD454 enrolled

Overview

Aim of the study is to evaluated the role of IGF1R and p95HER2 on prognosis in radically resected non small cell lung cancer patients The primary objective is to correlate the expression of IGF1R and p95HER2 with survival.

Study Type

OBSERVATIONAL

Enrollment

454

Conditions

Non Small Cell Lung Cancer

Interventions

Protein expression by immunohistochemistry and immunofluorescenceGENETIC

Protein expression by immunohistochemistry and immunofluorescence

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Radically resected non small cell lung cancer patients with tumor tissue available Exclusion Criteria: * Tumor tissue not available * Clinical data not available

Locations (1)

Istituto Clinco Humanitas

Rozzano, Milan, Italy

Outcomes

Primary Outcomes

Association of different biomarkers with survival

Time frame: At the end of enrollment

Secondary Outcomes

Association of a specific biomarker with patient's characteristics

Time frame: At the end of enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.